Rafferty Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 243,331 shares of BBIO stock, worth $6.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

243,331

Previous 271,607 10.41%

Holding current value

$6.76 Million

Previous $6.88 Million 9.94%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.91 - $31.3 $676,079 - $885,038	-28,276 Reduced 10.41%	243,331 $6.2 Million
Q2 2024 Aug 13, 2024	SELL	$23.0 - $31.04 $1.03 Million - $1.39 Million	-44,835 Reduced 14.17%	271,607 $6.88 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $1.1 Million - $1.63 Million	40,369 Added 14.62%	316,442 $9.78 Million
Q4 2023 Feb 13, 2024	SELL	$24.02 - $43.89 $896,162 - $1.64 Million	-37,309 Reduced 11.91%	276,073 $11.1 Million
Q3 2023 Nov 13, 2023	SELL	$16.89 - $35.01 $3.48 Million - $7.21 Million	-205,864 Reduced 39.65%	313,382 $8.26 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $2.37 Million - $3.21 Million	177,966 Added 52.15%	519,246 $8.93 Million
Q1 2023 May 11, 2023	SELL	$7.17 - $18.55 $2.71 Million - $7.01 Million	-377,989 Reduced 52.55%	341,280 $5.66 Million
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $866,285 - $1.48 Million	128,529 Added 21.76%	719,269 $5.48 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $1.09 Million - $1.7 Million	137,660 Added 30.38%	590,740 $5.87 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $886,335 - $2.07 Million	-170,122 Reduced 27.3%	453,080 $4.11 Million
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $3.5 Million - $8.19 Million	477,498 Added 327.72%	623,202 $6.33 Million
Q4 2021 Feb 10, 2022	BUY	$11.38 - $53.41 $953,905 - $4.48 Million	83,823 Added 135.46%	145,704 $2.43 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $987,925 - $1.35 Million	21,078 Added 51.66%	61,881 $2.9 Million
Q2 2021 Aug 10, 2021	SELL	$46.47 - $63.93 $285,651 - $392,977	-6,147 Reduced 13.09%	40,803 $2.49 Million
Q1 2021 May 10, 2021	BUY	$55.47 - $72.35 $1.76 Million - $2.3 Million	31,754 Added 208.96%	46,950 $2.89 Million
Q4 2020 Feb 10, 2021	SELL	$38.38 - $71.11 $1.12 Million - $2.07 Million	-29,059 Reduced 65.66%	15,196 $1.08 Million
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $297,731 - $461,811	10,946 Added 32.86%	44,255 $1.66 Million
Q2 2020 Aug 07, 2020	BUY	$22.22 - $35.69 $740,125 - $1.19 Million	33,309 New	33,309 $1.09 Million
Q1 2020 May 15, 2020	SELL	$16.11 - $36.23 $310,085 - $697,355	-19,248 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$17.96 - $46.63 $345,694 - $897,534	19,248 New	19,248 $675,000

Others Institutions Holding BBIO

# of Institutions

290

Shares Held

170M

Call Options Held

10.4M

Put Options Held

2.37M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.12B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History